Cubist Systematic Strategies’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Buy |
176,030
+175,630
| +43,908% | +$1.64M | 0.01% | 773 |
|
|
2025
Q1 | $4.91K | Sell |
400
-357,671
| -100% | -$4.39M | ﹤0.01% | 1373 |
|
|
2024
Q4 | $4.73M | Buy |
+358,071
| New | +$4.73M | 0.03% | 370 |
|
|
2023
Q4 | – | Sell |
-192,094
| Closed | -$2.79M | – | 2620 |
|
|
2023
Q3 | $2.79M | Buy |
+192,094
| New | +$2.79M | 0.02% | 657 |
|
|
2023
Q2 | – | Sell |
-7,920
| Closed | -$167K | – | 2958 |
|
|
2023
Q1 | $167K | Buy |
+7,920
| New | +$167K | ﹤0.01% | 2274 |
|
|
2022
Q2 | – | Sell |
-57,804
| Closed | -$1.01M | – | 4015 |
|
|
2022
Q1 | $1.01M | Buy |
57,804
+20,206
| +54% | +$351K | 0.01% | 2018 |
|
|
2021
Q4 | $823K | Buy |
37,598
+21,205
| +129% | +$464K | 0.01% | 2069 |
|
|
2021
Q3 | $313K | Sell |
16,393
-4,773
| -23% | -$91.1K | ﹤0.01% | 2330 |
|
|
2021
Q2 | $363K | Buy |
21,166
+4,415
| +26% | +$75.7K | ﹤0.01% | 2218 |
|
|
2021
Q1 | $375K | Sell |
16,751
-17,696
| -51% | -$396K | ﹤0.01% | 2122 |
|
|
2020
Q4 | $766K | Buy |
34,447
+26,747
| +347% | +$595K | 0.01% | 1543 |
|
|
2020
Q3 | $114K | Sell |
7,700
-7,761
| -50% | -$115K | ﹤0.01% | 2265 |
|
|
2020
Q2 | $229K | Buy |
+15,461
| New | +$229K | ﹤0.01% | 1974 |
|
|
2018
Q4 | – | Sell |
-2,144
| Closed | -$17K | – | 2247 |
|
|
2018
Q3 | $17K | Buy |
+2,144
| New | +$17K | ﹤0.01% | 1780 |
|
|
2017
Q2 | – | Sell |
-1,200
| Closed | -$16K | – | 1868 |
|
|
2017
Q1 | $16K | Sell |
1,200
-1,466
| -55% | -$19.5K | ﹤0.01% | 1557 |
|
|
2016
Q4 | $19K | Buy |
+2,666
| New | +$19K | ﹤0.01% | 1636 |
|